Findings for both men and women with a false-positive prostate or breast cancer test result.
Increased incidence of malignant disease, specifically prostate, melanoma, pancreas, breast cancers
Sexual dysfunction was a chief complaint among survey respondents with prostate cancer.
Myocarditis with ICIs may be more common than initially thought; responds to higher steroid dosages
A novel component of an interventional program was cognitive-behavioral counseling administered in a group setting to promote behavioral change.
Study shows that the risk of recurrence after salvage radiotherapy is inversely related to the number of nodes resected at radical prostatectomy.
In a study, race independently predicted prostate cancer-specific mortality beyond a number of risk factors, including health insurance status.
Low-dose AA with low-fat breakfast had greater effect on PSA; similar effect to standard dose
More and more cases of oligometastatic PCa are being diagnosed as a result of advances in molecular imaging, but clinical trial data about the best way to treat this disease entity are lacking.
Study identifies which PCa patients with positive lymph nodes may have improved survival with the addition of adjuvant radiotherapy to androgen-deprivation therapy.
Researchers concluded that a greater than 90-day interval from prostate biopsy to radical prostatectomy increases the risk of biochemical recurrence among men with Gleason 3+4 disease.
Effective clinical trial design and ultimately drug approval require careful consideration of the endpoints selected.
Study documents a drop in the incidence of de novo metastatic PCa from 1980 to 2011 in the United States.
New study shows that men are at lower risk of prostate cancer for years after they stop taking the medication.
In a large international trial, pre-biopsy MRI scans spared 28% of men from having to undergo a biopsy and resulted in a lower detection of clinically insignificant cancers vs standard biopsy.
Researchers observed reductions in biochemical failure and distant metastasis rates in patients who had dose-escalated radiation therapy.
However, mortality higher with conservative therapy in locally advanced, non-metastatic prostate cancer.
Findings from a large study of men in the United Kingdom do not support single PSA testing for population-based screening.
In a study, extremely dose-escalated radiotherapy combined with androgen deprivation therapy offered the best cancer-specific survival among men with Gleason 9-10 prostate cancer.
Not only is there immense state-by-state heterogeneity in PSA screening, but there is also marked variation within each state.
In a 12-month study, men with prostate cancer treated with ADT reported more nocturia episodes than men with prostate cancer treated with prostatectomy alone and men with no history of cancer.
Research suggests that men's diets can affect their risk for prostate cancer.
Multiparametic MRI findings added to conventional clinical predictors decreases the number of false-positive biopsy results without increasing the number of clinically significant tumors left undiagnosed, study finds.
Apalutamide prolonged metastasis-free survival by 2 years compared with placebo.
Added to hormone therapy, docetaxel offers a cost effective way to prolong hormone-sensitive disease and improve quality of life years, especially among men with non-metastatic disease, study finds.
Trials sponsored by academic investigators, cooperative groups more likely to use these criteria
In a small phase 2 study of overweight men with recurrent prostate cancer, consuming less than 20 grams of carbohydrates a day resulted in profound weight loss.
Metastasis and death are more likely to occur among patients with relatively high PSA levels at diagnosis of nmCRPC and rising PSA levels during follow-up.
Multiparametric MRI has high positive and negative predictive values for extracapsular extension, seminal vesicle invasion, lymph node involvement, and high-risk Gleason score.
In a study, nearly 20% of radical cystectomy patients were readmitted for complications within 90 days compared with 1.9% and 5.9% for radical prostatectomy and radical nephrectomy, respectively.
Renal and Urology News Articles
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)